Philippine bill calls for new drug price commission
This article was originally published in Scrip
Executive Summary
A Philippine congressman has filed a proposal calling for the establishment of a new independent commission to monitor the price of prescription drugs. Representative Narciso Santiago's house bill envisages the commission be tasked with reviewing prices in other reference countries, and monitoring and making recommendations on appropriate local price levels. It would also be responsible for proposing the structure, membership and function of a new price review board called for in cheaper medicines legislation approved earlier this year (Scrip Online, June 24th, 2008). The commission would in addition work out guidelines for starting prices and price increases, recommend fair pricing incentives for manufacturers and make regular reports to Congress, the bill states.
You may also be interested in...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: the shifting sands of pharma R&D; big pharma oncology strategies; semaglutide’s promise in heart failure; AstraZeneca looks to multiple cancer modalities; and an interview with Astellas’s chief strategy officer.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Genmab buys into ADCs; Roivant set to take on AbbVie in uveitis; Ipsen signs firs ADC pact; South Korea looks to build biotech momentum; and the end of the road for Acorda.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Merck & Co progresses cardiovascular strategy; Novo purchase builds heart failure presence; CRL setbacks for Regeneron; ITF faces challenging Duchenne field; and AbbVie needs to freshen up.